“They act very quickly on both itching and atopic inflammation with notable advantages for the quality of life of those who suffer from it. At the Eadv congress the results were presented with three Jak inhibitors used in clinical practice, including upatacitinib. In atopic dermatitis they allow you to reduce signs and symptoms, such as itching, by 95% – 100%”.
#Fargnoli #Sidemast #Jak #inhibitors #important #therapeutic #novelty #severe #moderate #atopic #dermatitis